Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After Intervention. (PubMed, Int J MS Care) - Oct 24, 2026 - "Wearing off was observed in nearly a quarter of people with MS receiving ocrelizumab. Clinicians should be aware of predictive factors for wearing off with ocrelizumab and that interventions were generally effective at mitigating this phenomenon."
Journal • CNS Disorders • Fatigue • Genetic Disorders • Multiple Sclerosis • Obesity
|
|
Alexandra Rincones; Avinash Kolli; Derrick S Robertson; John R Ciotti; Luis Compres Brugal; Marjorie Fitzsimmons
|